Precipio Inc (PRPO)
6.44
+0.09
(+1.42%)
USD |
NASDAQ |
Nov 14, 16:00
6.48
+0.04
(+0.62%)
After-Hours: 20:00
Precipio Enterprise Value: 9.021M for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 14, 2024 | 9.021M |
November 13, 2024 | 8.888M |
November 12, 2024 | 8.576M |
November 11, 2024 | 8.369M |
November 08, 2024 | 8.517M |
November 07, 2024 | 8.843M |
November 06, 2024 | 8.680M |
November 05, 2024 | 8.665M |
November 04, 2024 | 8.591M |
November 01, 2024 | 8.812M |
October 31, 2024 | 8.975M |
October 30, 2024 | 9.079M |
October 29, 2024 | 8.753M |
October 28, 2024 | 8.894M |
October 25, 2024 | 8.842M |
October 24, 2024 | 8.886M |
October 23, 2024 | 9.153M |
October 22, 2024 | 8.960M |
October 21, 2024 | 9.410M |
October 18, 2024 | 9.035M |
October 17, 2024 | 9.390M |
October 16, 2024 | 9.616M |
October 15, 2024 | 9.286M |
October 14, 2024 | 8.998M |
October 11, 2024 | 9.276M |
Date | Value |
---|---|
October 10, 2024 | 9.286M |
October 09, 2024 | 9.820M |
October 08, 2024 | 9.835M |
October 07, 2024 | 9.835M |
October 04, 2024 | 9.545M |
October 03, 2024 | 9.479M |
October 02, 2024 | 9.571M |
October 01, 2024 | 9.420M |
September 30, 2024 | 9.405M |
September 27, 2024 | 8.785M |
September 26, 2024 | 8.761M |
September 25, 2024 | 8.696M |
September 24, 2024 | 9.016M |
September 23, 2024 | 9.066M |
September 20, 2024 | 8.962M |
September 19, 2024 | 8.352M |
September 18, 2024 | 8.384M |
September 17, 2024 | 8.296M |
September 16, 2024 | 8.503M |
September 13, 2024 | 8.281M |
September 12, 2024 | 8.562M |
September 11, 2024 | 7.970M |
September 10, 2024 | 8.503M |
September 09, 2024 | 8.622M |
September 06, 2024 | 8.236M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.948M
Minimum
Sep 21 2023
105.59M
Maximum
May 20 2021
22.31M
Average
14.74M
Median
Enterprise Value Benchmarks
Bruker Corp | 10.45B |
Azenta Inc | 1.489B |
Harvard Bioscience Inc | 133.17M |
Bionano Genomics Inc | 24.95M |
Akoya Biosciences Inc | 185.39M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.626M |
Revenue (Quarterly) | 5.209M |
Total Expenses (Quarterly) | 5.806M |
EPS Diluted (Quarterly) | -0.42 |
Gross Profit Margin (Quarterly) | 43.71% |
Profit Margin (Quarterly) | -12.02% |
Earnings Yield | -28.42% |
Normalized Earnings Yield | -28.42 |